BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 18445697)

  • 41. Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer.
    Zuckerman IH; Rapp T; Onukwugha E; Davidoff A; Choti MA; Gardner J; Seal B; Mullins CD
    J Am Geriatr Soc; 2009 Aug; 57(8):1403-10. PubMed ID: 19563521
    [TBL] [Abstract][Full Text] [Related]  

  • 42. On informative detection bias in screening studies.
    Sjölander A; Humphreys K; Palmgren J
    Stat Med; 2008 Jun; 27(14):2635-50. PubMed ID: 17918781
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening mammography: a cross-sectional study to compare characteristics of women aged 40 and older from the deep South who are current, overdue, and never screeners.
    Lopez ED; Khoury AJ; Dailey AB; Hall AG; Chisholm LR
    Womens Health Issues; 2009; 19(6):434-45. PubMed ID: 19879455
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sensitivity analysis for m-estimates, tests, and confidence intervals in matched observational studies.
    Rosenbaum PR
    Biometrics; 2007 Jun; 63(2):456-64. PubMed ID: 17688498
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it?
    Havrilesky LJ; Sanders GD; Kulasingam S; Myers ER
    Gynecol Oncol; 2008 Nov; 111(2):179-87. PubMed ID: 18722004
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An early- and late-stage convolution model for disease natural history.
    Pinsky PF
    Biometrics; 2004 Mar; 60(1):191-8. PubMed ID: 15032789
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular subtypes of breast cancers detected in mammography screening and outside of screening.
    Sihto H; Lundin J; Lehtimäki T; Sarlomo-Rikala M; Bützow R; Holli K; Sailas L; Kataja V; Lundin M; Turpeenniemi-Hujanen T; Isola J; Heikkilä P; Joensuu H
    Clin Cancer Res; 2008 Jul; 14(13):4103-10. PubMed ID: 18593987
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Flexible parametric models for relative survival, with application in coronary heart disease.
    Nelson CP; Lambert PC; Squire IB; Jones DR
    Stat Med; 2007 Dec; 26(30):5486-98. PubMed ID: 17893893
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improving access to breast health services with an interdisciplinary model of care.
    Castellanos MR; Conte J; Fadel DA; Raia C; Forte F; Ahern K; Smith M; Elsayeh D; Buchbinder S
    Breast J; 2008; 14(4):353-6. PubMed ID: 18687070
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predicting impacts of mass-screening policy changes on breast cancer mortality.
    Seppänen J; Heinävaara S; Hakulinen T
    Stat Med; 2008 Nov; 27(25):5235-51. PubMed ID: 18613224
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estimating the cumulative risk of a false-positive test in a repeated screening program.
    Xu JL; Fagerstrom RM; Prorok PC; Kramer BS
    Biometrics; 2004 Sep; 60(3):651-60. PubMed ID: 15339287
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of magnetic resonance imaging in screening women at high risk of breast cancer.
    Warner E
    Top Magn Reson Imaging; 2008 Jun; 19(3):163-9. PubMed ID: 18941396
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Variance estimation of a survival function for interval-censored survival data.
    Sun J
    Stat Med; 2001 Apr; 20(8):1249-57. PubMed ID: 11304740
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stat bite: Cancer screening for women.
    J Natl Cancer Inst; 2007 Feb; 99(4):271. PubMed ID: 17312303
    [No Abstract]   [Full Text] [Related]  

  • 55. Quantification of length-bias in screening trials with covariate-dependent test sensitivity.
    Heltshe SL; Kafadar K; Prorok PC
    Biom J; 2015 Sep; 57(5):777-96. PubMed ID: 25980962
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The debate on breast cancer screening with mammography is important.
    Gøtzsche PC
    J Am Coll Radiol; 2004 Jan; 1(1):8-14. PubMed ID: 17411511
    [No Abstract]   [Full Text] [Related]  

  • 57. Weighted nonparametric maximum likelihood estimate of a mixing distribution in nonrandomized clinical trials.
    Liu C; Xie J; Zhang Y
    Stat Med; 2007 Dec; 26(29):5303-19. PubMed ID: 17497612
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Are older Rhode Island women receiving appropriate screening for breast cancer?
    Butler JB; Claflin M; Gifford DS
    Med Health R I; 2005 Oct; 88(10):368-9. PubMed ID: 16350942
    [No Abstract]   [Full Text] [Related]  

  • 59. Under-smoothed kernel confidence intervals for the hazard ratio based on censored data.
    Tu D
    Biom J; 2007 Jun; 49(3):474-83. PubMed ID: 17623350
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cure rate model with interval censored data.
    Kim YJ; Jhun M
    Stat Med; 2008 Jan; 27(1):3-14. PubMed ID: 17516589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.